Detalles de la búsqueda
1.
Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma.
Int J Cancer
; 152(7): 1490-1500, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36451312
2.
Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Ann Surg Oncol
; 29(9): 5666-5678, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35543906
3.
DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation.
Acta Pharmacol Sin
; 43(1): 157-166, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33758355
4.
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data update.
Chin J Cancer Res
; 34(1): 28-39, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355930
5.
PlGF knockdown attenuates hypoxia-induced stimulation of cell proliferation and glycolysis of lung adenocarcinoma through inhibiting Wnt/ß-catenin pathway.
Cancer Cell Int
; 21(1): 18, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407494
6.
Serum TNFRII: A promising biomarker for predicting the risk of subcentimetre lung adenocarcinoma.
J Cell Mol Med
; 24(7): 4150-4156, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073741
7.
Racial differences in characteristics and prognoses between Asian and white patients with nonsmall cell lung cancer receiving atezolizumab: An ancillary analysis of the POPLAR and OAK studies.
Int J Cancer
; 146(11): 3124-3133, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583695
8.
Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells.
Acta Pharmacol Sin
; 41(10): 1357-1365, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415222
9.
Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment.
Front Immunol
; 14: 1106090, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923412
10.
PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs.
J Control Release
; 362: 197-209, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37648084
11.
Combined large cell neuroendocrine carcinoma: clinical characteristics, prognosis and postoperative management.
Eur J Cardiothorac Surg
; 62(2)2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35147672
12.
Pembrolizumab Plus Chemotherapy Versus Chemotherapy Monotherapy as a First-Line Treatment in Elderly Patients (≥75 Years Old) With Non-Small-Cell Lung Cancer.
Front Immunol
; 13: 807575, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237263
13.
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma.
Cancer Med
; 11(5): 1299-1309, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023616
14.
Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study.
Thorac Cancer
; 13(5): 732-741, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35060346
15.
Clinical significance of visceral pleural and lymphovascular invasion in surgically resected adenosquamous lung cancer.
Eur J Cardiothorac Surg
; 59(3): 617-623, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200178
16.
Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations.
Front Oncol
; 11: 681429, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34485120
17.
Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.
Front Oncol
; 11: 714549, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34631540
18.
Pembrolizumab Alone or Combined With Chemotherapy in Advanced NSCLC With PD-L1 ≥50%: Results of a Retrospective Study.
Front Oncol
; 11: 691519, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262873
19.
TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer.
Front Immunol
; 12: 732125, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34603310
20.
Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC.
Front Oncol
; 11: 671228, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937084